Eli Lilly | chemanager-online.com - Chemistry and Life Science

Jan. 24, 2020
News & Opinions
Lilly to Build Injectables Plant in North Carolina
US drugmaker Eli Lilly is planning to invest $474 million in a new plant in North Carolina’s Research Triangle Park (RTP) that will produce injectable medicines such as insulin, as well as delivery systems such as pens, from 2023. ...
Dec. 20, 2019
News & Opinions
US to Allow Drug Reimports from Canada
The US Department of Health and Human Services (HHS) is proposing that state governments allow drugmakers to reimport their products from Canada, where they are generally cheaper due to the country’s single-payer program, and make ...
Nov. 21, 2019
News & Opinions
Lilly in $400 Million Expansion at Indianapolis
Eli Lilly is investing $400 million at its Lilly Technology Center campus in Indianapolis, Indiana, USA, to expand capacity for its growing portfolio of diabetes medicines and provide additional manufacturing capacity for future medicines ...
Sep. 13, 2019
Topics
Injecting Growth and Innovation
Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several billion-dollar acquisitions. This is an attempt to ...
Aug. 23, 2019
News & Opinions
Lilly Wins Alimta Appeal
US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories.
Jul. 18, 2019
News & Opinions
Bayer and Elanco Animal Health Link-up?
Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare down debt after its $63 billion takeover of Monsanto in ...
Apr. 30, 2019
News & Opinions
Lilly and Avidity Biosciences Partner on New Drugs
Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications.
Apr. 08, 2019
Topics
The Need for Innovation in Pharmaceutical Manufacturing
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs ...
Nov. 02, 2018
News & Opinions
DCAT Announces New Board of Directors
Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Stephan Kutzer, ...
May. 17, 2018
News & Opinions
Eli Lilly to Buy AurKa Pharma and ARMO
US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A inhibitor, was originally discovered by Lilly, which ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag